Trevi Therapeutics Inc (NASDAQ:TRVI) Stock Rockets 25% After The News
Trevi Therapeutics Inc. (NASDAQ: TRVI) jumped 25% as investors reacted positively to the company’s SEC filing. According to the SEC filing, Trevi Therapeutics has applied for a Registration Statement withdrawal that was initially filed with the US SEC on August 27, 2021. The company had filed the statement in connection with its proposed public offering for its ordinary shares, par value $0.001 per share. However, Trevi Therapeutics has decided not…